Search Results 71-80 of 30253 for Hepatitis C

  1. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus ...

  2. A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis - Mayo Clinic

    A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and ...

  3. 'I Have a Vision of Working at a Global Scale' - News Archive - Mayo Clinic College of Medicine & Science

    Chronic hepatitis C can result in long-term health problems, but the majority may not be aware of the infection. "Hepatitis is one of those hidden illnesses ...

  4. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  5. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  6. Ribavirin (Oral Route) Proper Use - Mayo Clinic

    For hepatitis C virus infection, in combination with peginterferon alfa-2b: For oral dosage form (capsules):. Adults—Dose is based on body weight and must be ...

  7. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

    ... Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo ...

  8. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  9. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Overview. Tab Title Description. Study typeObservational Study IDs. Study type. Observational. Describes the nature of a clinical study ...

  10. The Making of an Expert - Mayo Clinic News Network

    Hepatitis C is spread by blood and becomes a long-term, chronic infection for 70% to 85% of infected people. Chronic hepatitis C can result in long-term ...